Taking the above results together, it can be concluded that ZNF582 expression is significantly decreased in ccRCC, and decreased ZNF582 expression is associated with higher tumor stage and grade, distant metastasis and poor prognosis of ccRCC patients. This evidence concerns the gene ZNF582 and nonpapillary renal cell carcinoma.